STAT

The Ebola response effort is struggling. Experts say these steps could help

The Ebola containment effort is struggling. Experts say there's a way to right the response.
Health workers carry the coffin containing of an Ebola victim in Butembo, in the Democratic Republic of the Congo. Source: JOHN WESSELS/AFP/Getty Images

With Ebola response teams struggling to contain the outbreak in the Democratic Republic of the Congo, the World Health Organization and its partners can make changes to shore up their effort and try to prevent the crisis from escalating further, according to a handful of experts surveyed by STAT.

The experts are wary of criticizing WHO officials and others trying desperately to stop the virus from spreading. Violence aimed at Ebola response workers and a refusal to cooperate with control measures in some communities has rendered this outbreak, the second largest on record, unlike anything the world of Ebola responders has seen before. There have been repeated attacked on Ebola treatment centers, and on many days response workers have been unable to move about in outbreak hotspots.

At the same time, the experts believe global health officials have opportunities to bolster their efforts.

Here are three.

Good data are key

The foundation

You're reading a preview, sign up to read more.

More from STAT

STAT7 min readPolitics
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.
STAT6 min readSociety
Opinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions
For more than a decade, biosimilars have flourished in Europe. That hasn't happened in the U.S. because of misinformation and poor market preparation.
STAT3 min readPolitics
With Eyes On Gilead, Lawmakers Want Details On How HHS Reviews Possible Patent Infringement
After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.